DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pritumumab
Pritumumab
2017 Immuno-Oncology Medicines in Development
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
Customs Tariff - Schedule
(INN) for Biological and Biotechnological Substances
EP3027208T3.Pdf
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
INN Working Document 05.179 Update December 2010
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
2018 Medicines in Development for Cancer
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
A61K9/51 (2006.01) — with International Search Report (Art
| Hao Hata Kata Tai Mit on a Man Taiwan Ta Material
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
Top View
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
(12) United States Patent (10) Patent No.: US 8,815,247 B2 Govindappa Et Al
Methods and Compositions for Prediction of Therapeutic Efficacy of Cancer Treatments and Cancer Prognosis Upon Antibody Treatment
2020 Medicines in Development ꟷ Cancer
Assessment of the Evolution of Cancer Treatment Therapies
Pharmaabkommen A1 E
(12) United States Patent (10) Patent No.: US 9.295,731 B2 Nguyen (45) Date of Patent: Mar
Thi Na Mtu Mtu Hulumtottuk
WO 2017/096163 Al 8 June 2017 (08.06.2017) W P O P C T
Orphan Drug Designations and Approvals List As of 06‐01‐2015 Governs July 1, 2015 ‐ September 30, 2015
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
International Journal of Current Advanced Research
Pritumumab, the First Therapeutic Antibody for Glioma Patients
Protein-Polymer-Drug Conjugates Protein-Polymer-Wirkstoffkonjugate Conjugués De Médicament-Protéine-Polymère
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
Assessment of the Evolution of Cancer Treatment Therapies
Timepoint 1 Geting Assembly Complexes (Attacs) for Selectively Activating De¬ Sired Immune Cells in the Tumor Microenvironment
Assessment of the Evolution of Cancer Treatment Therapies
Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri